Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10.
暂无分享,去创建一个
Mu-yang Huang | Zi-han Ye | Xin He | Jin-Jian Lu | Can-Yu Huang | Xiaobing Chen | Yu-Chi Chen | Wenyu Lyu | Xinyu He | Xiuping Chen | Baoxian Zhang | Guoyin Kai | Xiaolei Zhang | Ting Li | Mingqing Huang | Wen-Yu Lyu